0.681
price down icon1.02%   -0.007
after-market Handel nachbörslich: .72 0.039 +5.73%
loading

Finanzdaten der Unity Biotechnology Inc-Aktie (UBX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
1.02%
7.599
7.677 14.58 11.85 10.56
Interest Income/Expense
100.00%
-
0.001 0.566 0.883 1.002
Operating Income/Loss
1.02%
-7.599
-7.677 -14.58 -11.85 -10.56
Income/Loss From Continuing Operations Before Tax
33.41%
-5.79
-4.34 -14.78 -15.46 -5.279
Income/Loss From Continuing Operations After Tax
33.41%
-5.79
-4.34 -14.78 -15.46 -5.279
Net Income/Loss
33.41%
-5.79
-4.34 -14.78 -15.46 -5.279
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,034%
16.79
0.3269 14.60 14.43 14.31
Diluted Average Shares
5,034%
16.79
0.3269 14.60 14.43 14.31
Basic Earnings Per Share
41.67%
-0.34
-0.24 -1.01 -1.07 -0.37
Diluted Earnings Per Share
41.67%
-0.34
-0.24 -1.01 -1.07 -0.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$73.62
price up icon 1.21%
$22.20
price up icon 1.79%
$20.59
price up icon 4.36%
$33.78
price up icon 0.09%
$108.49
price down icon 1.51%
biotechnology ONC
$255.86
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):